Clinical Trial Update: Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Advanced Gynecologic Malignancies and Breast [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and tolerability of combining Niraparib with Everolimus in advanced gynecologic malignancies and breast cancer; results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Drugs mentioned

• Afinitor (everolimus)
• Zejula (Niraparib)

Snippet

Sponsor: Avera McKennan Hospital & University Health Center | Conditions: Breast Cancer, Ovarian Cancer | Phase 1 | Status: COMPLETED | Results posted: 2024-08-01